Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function

G R Flentke, E Munoz, B T Huber, A G Plaut, C A Kettner, W W Bachovchin, G R Flentke, E Munoz, B T Huber, A G Plaut, C A Kettner, W W Bachovchin

Abstract

Dipeptidyl peptidase IV (DP-IV; dipeptidyl-peptide hydrolase, EC 3.4.14.5) is a serine protease with a specificity for cleaving Xaa-Pro dipeptides from polypeptides and proteins. It is found in a variety of mammalian cells and tissues, including those of lymphoid origin where it is found specifically on the surface of CD4+ T cells. Although the functional significance of this enzyme has not been established, a role in T-cell activation and immune regulation has been proposed. Here we report that Ala-boroPro and Pro-boroPro, where boroPro is the alpha-amino boronic acid analog of proline, are potent and specific inhibitors of DP-IV, having Ki values in the nanomolar range. Blocking the N terminus of Ala-boroPro abolishes the affinity of this inhibitor for DP-IV, while removal of the N-terminal residue, to give boroPro, reduces the affinity for DP-IV by 5 orders of magnitude. The dipeptide boronic acids exhibit slow-binding kinetics, while boroPro does not. We also report here that low concentrations of Pro-boroPro inhibit antigen-induced proliferation and interleukin 2 production in murine T-cell lines but do not inhibit the response of these T cells to the mitogen concanavalin A. These results indicate that DP-IV plays a role in antigen-induced, but not mitogen-induced, activation of T lymphocytes.

References

    1. Br J Haematol. 1982 Jun;51(2):227-34
    1. Eur J Biochem. 1982 Aug;126(2):359-65
    1. Eur J Biochem. 1980 Oct;111(1):49-58
    1. Acta Biol Med Ger. 1978;37(3):409-20
    1. Eur J Biochem. 1978 Oct 16;90(3):489-98
    1. Acta Chem Scand. 1968;22(1):299-308
    1. J Biol Chem. 1989 Apr 15;264(11):6037-43
    1. J Clin Invest. 1989 May;83(5):1533-40
    1. Scand J Immunol. 1989 Feb;29(2):127-32
    1. Biochemistry. 1988 Oct 4;27(20):7682-8
    1. J Biol Chem. 1989 Apr 5;264(10):5852-60
    1. Am J Physiol. 1987 Apr;252(4 Pt 2):F670-7
    1. Eur J Immunol. 1987 Dec;17(12):1821-6
    1. Cell Immunol. 1988 May;113(2):423-34
    1. Acta Histochem. 1987;82(1):41-6
    1. Eur J Biochem. 1986 Oct 1;160(1):31-5
    1. Biochim Biophys Acta. 1988 May 18;954(2):161-9
    1. Cell Immunol. 1985 Jun;93(1):199-211
    1. Biochim Biophys Acta. 1985 Aug 23;830(3):341-4
    1. Histochem J. 1985 Jul;17(7):737-71
    1. FEBS Lett. 1985 May 20;184(2):273-7
    1. Biol Chem Hoppe Seyler. 1985 Dec;366(12):1169-76
    1. J Clin Invest. 1986 Oct;78(4):906-13
    1. Cell Immunol. 1984 Nov;89(1):11-9
    1. J Biol Chem. 1990 Mar 5;265(7):3738-43
    1. J Clin Invest. 1983 Aug;72(2):610-6

Source: PubMed

3
Iratkozz fel